Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839202 · ClinicalTrials.gov registry record · NA
Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00839202: Completed NA study, sponsored by Children's Hospital Los Angeles.
NCT00839202 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00839202, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
A novel immuno-assay is being evaluated for the measurement of Factor VIII. Current procedure measures a rate assay which is subject to much artefact. The hypothesis is that the new assay will give a reading of absolute quantities of FVIII which will provide a more suitable indicator of FVIII content for clotting factor manufacturers, physicians and patients.
Interventions
- OTHER FVIII immuno-assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00839202 record still lists
NCT00839202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which FVIII immuno-assay is the first listed.
NCT00839202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00839202 about?
NCT00839202 is a clinical study titled "Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay". A novel immuno-assay is being evaluated for the measurement of Factor VIII. Current procedure measures a rate assay which is subject to much artefact. The hypothesis is that the new assay will give a reading of absolute quantities of FVIII which will provide a more suitable indicator of FVIII conten...
What is the current status of trial NCT00839202?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2006-09. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00839202?
The interventions under investigation include: FVIII immuno-assay (OTHER).
Who is sponsoring clinical trial NCT00839202?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00839202's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia